M. Ruisi

发表

Reduced Expression of Annexin A2 is Associated with Impaired Cell Surface Fibrinolysis and Venous Thromboembolism.

K. Hajjar, M. Desancho, H. Fassel, 2021, Blood.

Avelumab vs docetaxel in patients with platinum-treated advanced non-small-cell lung cancer: 2-year follow-up from the JAVELIN Lung 200 phase 3 trial.

Keunchil Park, F. de Marinis, M. Krzakowski, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay

K. Kerr, E. Vokes, Hulin Jin, 2020 .

Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series

E. Lipson, N. Ibrahim, K. Shirai, 2014, Journal of Immunotherapy for Cancer.

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.

Keunchil Park, F. de Marinis, M. Krzakowski, 2018, The Lancet. Oncology.

Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor

K. Kelly, H. Safran, D. Spigel, 2022, Future oncology.

Avelumab Dose Selection for Clinical Studies in Pediatric Patients with Solid Tumors

Y. Vugmeyster, Akash Khandelwal, B. Brockhaus, 2022, Clinical Pharmacokinetics.

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

K. Savage, J. Wolchok, J. Larkin, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.

C. Horak, R. Sullivan, J. Sosman, 2016, The Lancet. Oncology.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.

J. Bussel, B. Psaila, M. Forestier, 2011, Blood.

Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial.

Keunchil Park, J. Vansteenkiste, J. Yang, 2021, Lung cancer.

Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization

J. Bussel, M. J. Ward, B. Psaila, 2009, American journal of hematology.

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

A. Ravaud, L. Dirix, J. Infante, 2020, Journal for ImmunoTherapy of Cancer.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.